NO982877D0 - Process for preparing epoxy steroid - Google Patents

Process for preparing epoxy steroid

Info

Publication number
NO982877D0
NO982877D0 NO982877A NO982877A NO982877D0 NO 982877 D0 NO982877 D0 NO 982877D0 NO 982877 A NO982877 A NO 982877A NO 982877 A NO982877 A NO 982877A NO 982877 D0 NO982877 D0 NO 982877D0
Authority
NO
Norway
Prior art keywords
preparing epoxy
epoxy steroid
steroid
preparing
epoxy
Prior art date
Application number
NO982877A
Other languages
Norwegian (no)
Other versions
NO982877L (en
Inventor
Xiaoyong Fu
Tiruvettipuram K Thiruvengadam
Chou-Hong Tann
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO982877D0 publication Critical patent/NO982877D0/en
Publication of NO982877L publication Critical patent/NO982877L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)
NO982877A 1995-12-20 1998-06-19 Method of Preparation of Epoxy Stereoid NO982877L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57556295A 1995-12-20 1995-12-20
PCT/US1996/019600 WO1997022616A1 (en) 1995-12-20 1996-12-18 PROCESS FOR PREPARATION OF 9,11β-EPOXIDE STEROIDS

Publications (2)

Publication Number Publication Date
NO982877D0 true NO982877D0 (en) 1998-06-19
NO982877L NO982877L (en) 1998-08-20

Family

ID=24300812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982877A NO982877L (en) 1995-12-20 1998-06-19 Method of Preparation of Epoxy Stereoid

Country Status (12)

Country Link
EP (1) EP0873352A1 (en)
JP (1) JP2000502102A (en)
KR (1) KR20000064495A (en)
CN (1) CN1209138A (en)
AU (1) AU1331097A (en)
BR (1) BR9612064A (en)
CZ (1) CZ191398A3 (en)
IL (1) IL125004A0 (en)
MX (1) MX9804957A (en)
NO (1) NO982877L (en)
PL (1) PL327141A1 (en)
WO (1) WO1997022616A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5780521B2 (en) 2008-05-28 2015-09-16 リベラジェン・バイオファーマ・インコーポレイテッドReveraGen BioPharma,Inc. Non-hormonal steroid modulators of NF-κB for treating diseases
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc Non-hormonal steroid modulators of nf- kappa b for treatment of disease
CN103588853A (en) * 2013-11-28 2014-02-19 浙江省天台县奥锐特药业有限公司 Method for preparing 9,11beta-epoxy steroid compound
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN107266519B (en) * 2016-04-08 2021-06-29 天津金耀集团有限公司 Novel crystal form of 9 beta, 11 beta-epoxy-17 alpha-hydroxy-16 alpha-methyl-21-chloro-1, 4 pregnadiene-3, 20-diketone and preparation method thereof
CN109180767A (en) * 2018-09-04 2019-01-11 浙江仙琚制药股份有限公司 A method of preparing momestasone furoate
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1145170B (en) * 1959-03-13 1963-03-14 Scherico Ltd Process for the preparation of 9,11-oxidosteroids of the androstane and pregnane series
GB1244604A (en) * 1967-08-25 1971-09-02 Organon Labor Ltd Substituted methylene steroids and their preparation
GB1416427A (en) * 1972-01-12 1975-12-03 Akzo Nv Alkylated pregnanes and process for obtaining same
DE2617655C2 (en) * 1976-04-21 1984-11-08 F. Hoffmann-La Roche & Co Ag, Basel Corticoids, processes for their production and pharmaceutical preparations containing them
DE3064460D1 (en) * 1979-01-24 1983-09-08 Akzo Nv Novel alkylated pregnanes, processes for their preparation and pharmaceutical compositions containing same
DD268954A1 (en) * 1983-04-22 1989-06-14 Jenapharm Veb PROCESS FOR THE PREPARATION OF 9ALPHA HALOGEN 11BETA FORMYLOXYSTEROIDS OF THE PREGNANIUM SERIES
FR2675146A1 (en) * 1991-04-10 1992-10-16 Roussel Uclaf NOVEL STEROUID DERIVATIVES OF PREGNA-1,4-DIENE-3,20-DIONE, THEIR PREPARATION, THEIR APPLICATION TO THE PREPARATION OF SUBSTITUTED 16,17-METHYLENE DIOXY DERIVATIVES, AND NOVEL INTERMEDIATES

Also Published As

Publication number Publication date
CZ191398A3 (en) 1998-11-11
CN1209138A (en) 1999-02-24
WO1997022616A1 (en) 1997-06-26
PL327141A1 (en) 1998-11-23
KR20000064495A (en) 2000-11-06
EP0873352A1 (en) 1998-10-28
IL125004A0 (en) 1999-01-26
NO982877L (en) 1998-08-20
AU1331097A (en) 1997-07-14
JP2000502102A (en) 2000-02-22
BR9612064A (en) 1999-02-23
MX9804957A (en) 1998-09-30

Similar Documents

Publication Publication Date Title
NO972645L (en) Process for preparing an ester
FI945856A (en) Method for preparing level-off-DP cellulose
FI102474B1 (en) Process for the preparation of polyhydric alcohols
NO981800L (en) Process for the preparation of 1,1,1,3,3-pentafluoropentane
NO960362D0 (en) Process for preparing polyorganosiloxane resins
DE69620107T2 (en) crystallization process
KR970001365A (en) Method for preparing alkylhydrogenchlorosilane
HUP9900318A3 (en) Process for preparing 4-aryl-piperidine derivatives
NO20004738D0 (en) Process for preparing an epoxide
NO974169D0 (en) Process for tetra-azacycloalkane preparation
NO982237L (en) Process for the preparation of phenylimidazolidine derivatives
NO964867D0 (en) Process for preparing color concentrates
KR970702922A (en) Process for preparing doxorubicin
NO982877D0 (en) Process for preparing epoxy steroid
FI971035A0 (en) Bioconversion process for synthesizing trans-hydroxysulfone
NO950902L (en) Process for the preparation of methyl chlorosilanes
IL118992A (en) Process for preparing norbenzomorphan derivatives
NO963187D0 (en) Process for the synthesis of gamma-pyrones
IL118200A0 (en) Process for the preparation of substituted 2-fluoro-pyrimidines
KR970006291A (en) Method for producing substituted aminocarbonyltriazolinone
DE69500635T2 (en) Single point bond process
KR970001321A (en) Method for preparing 2-pyrrolidone
FI973341A0 (en) Process for the preparation of organosilanes
EP0751112A3 (en) Process for preparing aryliden substituted alkylcycloalkanones
NO972129D0 (en) Process for the preparation of 1-halo-3-trialkylsilanyl-benzene derivatives